Microfluidic Devices Patent Monitor Market Service: Gain On-going Insights into the Well-established Growing Market
04 déc. 2020 05h19 HE
|
Research and Markets
Dublin, Dec. 04, 2020 (GLOBE NEWSWIRE) -- The "Microfluidic Devices Patent Monitor" newsletter has been added to ResearchAndMarkets.com's offering. Microfluidic is a well-established growing...
Fluidigm to Participate at the Piper Sandler 32nd Annual Virtual Healthcare Conference
20 nov. 2020 21h54 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
3D Cell Culture Industry in Europe to 2025 - Featuring Corning, Lonza Group and Reprocell Among Others
19 nov. 2020 07h33 HE
|
Research and Markets
Dublin, Nov. 19, 2020 (GLOBE NEWSWIRE) -- The "Europe 3D Cell Culture Market By Product (Scaffold-Based 3D Cell Cultures, Scaffold-Free 3D Cell Cultures, Microfluidics, Magnetic Levitation), By End...
Fluidigm to Present at Upcoming Health Care Investor Conference
10 nov. 2020 08h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Global Distribution Partnering Deals in Pharma, Biotech and Diagnostics Directory 2020: Access to 2,000+ Distribution Deal Documents Since 2014
12 oct. 2020 08h54 HE
|
Research and Markets
Dublin, Oct. 12, 2020 (GLOBE NEWSWIRE) -- The "Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2020" report has been added to ResearchAndMarkets.com's...
Fluidigm Announces Conference Call and Webcast of Third Quarter 2020 Financial Results
06 oct. 2020 16h02 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Fluidigm Achieves Initial Milestone under NIH Rapid Acceleration of Diagnostics Agreement
08 sept. 2020 08h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Fluidigm Granted FDA Emergency Use Authorization for Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay for COVID-19
25 août 2020 23h00 HE
|
Fluidigm Corporation
Easy-to-Administer Saliva Test for COVID-19 Available for Immediate Shipment Extraction-Free, Real-Time PCR Workflow with Capacity of up to 6,000 Tests per Day per System Demonstrated 100 Percent...
HEIDENHAIN-IMT Microfluidics Paper Available
18 août 2020 10h02 HE
|
HEIDENHAIN CORPORATION
San Jose, CA, Aug. 18, 2020 (GLOBE NEWSWIRE) -- A new technical paper detailing the results of a unique bonding process in microfluidic devices is now available from HEIDENHAIN and IMT of the...
Fluidigm Announces Second Quarter 2020 Financial Results
06 août 2020 16h05 HE
|
Fluidigm Corporation
Second Quarter Revenue Decreased 8 Percent to $26.1 Million Filed for FDA Emergency Use Authorization for COVID-19 Saliva-based Test Multi-Site U.S. Study of COVID-19 Patients Utilizes Mass...